TRI-611 Degrades ALK Fusions Through a Distal Site

Company Triana Biomedicines Event Type Peer-Reviewed Publication Modality Oral, Brain-Penetrant Cereblon Molecular-Glue Degrader Asset TRI-611 Target ALK Fusion Proteins (Distal Surface, Cereblon-Dependent) Disease Area ALK-Positive Advanced Solid Tumors Summary A Nature paper published online September 9 reports that TRI-611 is an oral, brain-penetrant cereblon molecular-glue…